Fueling the Future: Centrus Energy's Strategic Expansion in Nuclear Enrichment

Outstanding Financial Performance in the Second Quarter

During the second quarter of 2026, Centrus Energy experienced a remarkable 14% surge in revenue compared to the previous year, reaching an impressive $176.1 million. The company reported a gross profit of $49.9 million, operating income of $10.4 million, and a net income of $16.8 million. Furthermore, the adjusted net income stood at a robust $38.7 million, translating to $1.77 per diluted share, underscoring a period of strong financial health and operational efficiency.

Record-Breaking Backlog and Strategic Market Positioning

Centrus concluded the quarter with an expanded commercial backlog totaling $4.5 billion, extending through 2040. This substantial backlog includes $3.7 billion within its Low-Enriched Uranium (LEU) segment and $800 million in its Technical Solutions division. A significant portion of this growth, approximately $600 million, stemmed from increased sales of LEU and High-Assay Low-Enriched Uranium (HALEU) enrichment services, with about $2.4 billion under definitive agreements. This reflects the rising demand and Centrus's strategic advantage in the nuclear fuel market.

Securing Future Growth: Government Contracts and Industry Partnerships

A major development during the quarter was the signing of a $900 million task order with the Department of Energy. This non-dilutive, non-debt funding is pivotal for scaling up Centrus's LEU and HALEU production capacities, transitioning from technology demonstration to large-scale commercial output. Additionally, Centrus announced new HALEU supply agreements with Oklo and X-energy, signaling strong industry confidence and securing future demand for advanced nuclear fuels.

Operational Excellence and Workforce Expansion Initiatives

Centrus successfully completed its HALEU production requirements under its existing DOE demonstration contract ahead of schedule, showcasing its operational efficiency. The company plans to accelerate capital spending throughout 2026, maintaining its revenue guidance of $450 million to $500 million. To support its ambitious expansion, Centrus has increased its hiring target for its Piketon facility to over 175 new employees and expects to complete its first centrifuge at the Oak Ridge manufacturing plant in 2026, with commercial production slated for 2029.

Insights into Segment Performance and Investment in Advanced Technologies

The LEU segment's revenue saw a 22% increase to $153.4 million, despite a decrease in separative work unit (SWU) volumes, which was offset by higher average SWU prices and $53.4 million in uranium sales. Conversely, the Technical Solutions segment experienced a 21% decline due to a decrease in revenue from HALEU operations. The company's net income was impacted by increased selling, general, and administrative expenses, including advanced technology costs associated with manufacturing readiness and security training for its expansion sites in Piketon, Ohio, and Oak Ridge, Tennessee.

Strategic Outlook and Future Milestones

Centrus is dedicated to meeting the growing global demand for nuclear fuel, emphasizing the importance of LEU for existing reactors and HALEU for next-generation advanced reactors. The company plans to leverage customer prepayments as a non-dilutive funding source for its expansion efforts. An upcoming investor day in December at its American Centrifuge plant in Piketon will offer further insights into its strategic direction and future growth prospects.